AbbVie (NYSE:ABBV) has lowered its 2024 earnings forecast due to the impact of certain R&D and acquisition-related expenses it expects to record in the third quarter
https://seekingalpha.com/news/4156300-abbvie-lowers-2024-earnings-forecast-by-004-per-share
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.